Download
1 / 4
40 likes | 43 Vues
The global pre-menstrual syndrome treatment market size is projected to grow at the CAGR of over 3% market during the forecast period 2020 to 2027 and accounted for around USD 1.5 billion in 2019. Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffers from PMS; and one in every twenty women demonstrates life disturbing symptoms. PMDD occurs in 3% to 5% of menstruating women. Though the exact cause of PMS is unknown, it is reported that fluctuating levels of hormones (estrogen and progesterone) are related to PMS symptoms. The treatment regimen of PMS is temporary i.e. administered only for symptom management before the onset of the menstrual cycle. Education, nutrition, exercise, and medication together form the complete layout of the PMS treatment module.
E N D
Global Pre-menstrual Syndrome Treatment Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027 Request a Free Sample @ https://www.researchcorridor.com/request-sample/?id=144540 Media Contact: Company Name: Research Corridor Contact Person: Mr. Vijendra Singh Email: sales@researchcorridor.com Contact no: +91 989-368-5690
Theglobal pre-menstrual syndrome treatment market size is projected to grow at the CAGR of over 3% market during the forecast period 2020 to 2027 and accounted for around USD 1.5 billion in 2019. Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffers from PMS; and one in every twenty women demonstrates life disturbing symptoms. PMDD occurs in 3% to 5% of menstruating women. Though the exact cause of PMS is unknown, it is reported that fluctuating levels of hormones (estrogen and progesterone) are related to PMS symptoms. The treatment regimen of PMS is temporary i.e. administered only for symptom management before the onset of the menstrual cycle. Education, nutrition, exercise, and medication together form the complete layout of the PMS treatment module. The report titled "Pre-menstrual Syndrome Treatment Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2027" offers a holistic view of the Pre-menstrual Syndrome Treatment industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global Pre- menstrual Syndrome Treatment market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry. Browse Full report on Global Pre-menstrual Syndrome Treatment Market report at: https://www.researchcorridor.com/pre-menstrual-syndrome-treatment-market/ The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies. Pre-menstrual Syndrome Treatment Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis. Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years. The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market. The Data Pre-menstrual Syndrome Treatment Market Segmentation: By Drug Type, 2018–2027 ($ Millon) Analgesics (pain killers) Oral Contraceptive Pills (OCPs) Gonadotropin-releasing Hormone (GnRH) Antidepressants Ovarian Suppressors Diuretics Benzodiazepines • • • • • • •
By Geography, 2018-2027 ($ Millon) North America Europe Asia Pacific Latin America (LATAM) Middle East and Africa (MEA) • • • • • To know more about the study, make an inquiry before purchase @ https://www.researchcorridor.com/inquiry/?id=144540 List of Key Companies: •Alva-Amco Pharmacal Cos., Inc. •Bayer, Inc. •Chattem, Inc. (Sanofi) •DEKK-TEC, Inc. •R. Lane Health Products Ltd •McNeil Consumer Healthcare •MetP Pharma AG •Pherin Pharmaceuticals, Inc. •Umecrine Mood AB •Novartis AG •GlaxoSmithKline Plc Key Questions Answered by Pre-menstrual Syndrome Treatment Market Report •Product popularity and adoption based on various country-level dynamics •Regional presence and product development for leading market participants •Market forecasts and trend analysis based on ongoing investments and economic growth in key countries •Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others •number of employees and market concentration, among others To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=144540 About Us: Research Corridor is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid
businesses identify market opportunities optimize strategies. Our expert’s team of analysts provides enterprises with strategic insights. Research Corridor works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at sales@researchcorridor.com . Media Contact: Company Name: Research Corridor Contact Person: Mr. Vijendra Singh Email: sales@researchcorridor.com Contact no: +91 989-368-5690 Visit us: https://www.researchcorridor.com/
